MADISON, WIS. — OCT 8, 2020 – First Business Growth Funding, a division of First Business Capital Corp., announced today that it is financing multiple COVID-19 vaccine trials at various sites throughout the United States. The COVID-19 vaccine trials are in Stages II and III and involve thousands of subjects.

Bill Elliott, President of First Business Growth Funding, stated, “We are excited to be able to do our small part to help fight this disease. This type of financing does not fit the norms of traditional factoring, so we had to be creative in structuring a program that benefits our clients while also maintaining our credit integrity. We are very proud of the work that our clients are doing on the front lines.”

About First Business Growth Funding
First Business Growth Funding, the accounts receivable financing arm of First Business Financial Services, Inc., provides factoring solutions to service providers, importers, and manufacturers of all sizes throughout the United States with transactions ranging from $100,000 to $10 million.

About First Business Bank
First Business Financial Services, Inc. (Nasdaq: FBIZ) is a bank holding company and parent of First Business Bank focused on the unique needs of businesses, business executives, and high net worth individuals. First Business offers business banking, specialty finance, and private wealth management solutions, and, through its niche focus, provides clients with unmatched expertise, accessibility, and responsiveness.